A Phase 2, Double-blind, Randomized, Placebo-controlled Pharmacokinetic Trial in 2 Parallel Groups to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and GWP42003-P in Patients With Epilepsy
Phase of Trial: Phase II
Latest Information Update: 04 Nov 2017
At a glance
- Drugs Cannabidiol (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors GW Pharmaceuticals
- 30 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Aug 2019.
- 30 Oct 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Aug 2019.
- 24 Oct 2016 Status changed from not yet recruiting to recruiting.